Next-Generation Sequencing Technologies Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Next-Generation Sequencing Technologies Market 

5.1. COVID-19 Landscape: Next-Generation Sequencing Technologies Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Next-Generation Sequencing Technologies Market, By Technology

8.1. Next-Generation Sequencing Technologies Market, by Technology

8.1.1. WGS

8.1.1.1. Market Revenue and Forecast

8.1.2. Whole Exome Sequencing             

8.1.2.1. Market Revenue and Forecast

8.1.3. Targeted Sequencing & Resequencing

8.1.3.1. Market Revenue and Forecast

8.1.4. Others

8.1.4.1. Market Revenue and Forecast

Chapter 9. Global Next-Generation Sequencing Technologies Market, By Application

9.1. Next-Generation Sequencing Technologies Market, by Application

9.1.1. Oncology

9.1.1.1. Market Revenue and Forecast

9.1.2. Clinical Investigation

9.1.2.1. Market Revenue and Forecast

9.1.3. Reproductive Health

9.1.3.1. Market Revenue and Forecast

9.1.4. HLA Typing/Immune System Monitoring

9.1.4.1. Market Revenue and Forecast

9.1.5. Metagenomics, Epidemiology & Drug Development

9.1.5.1. Market Revenue and Forecast

9.1.6. Agrigenomics & Forensics

9.1.6.1. Market Revenue and Forecast

9.1.7. Consumer Genomics

9.1.7.1. Market Revenue and Forecast

Chapter 10. Global Next-Generation Sequencing Technologies Market, By Workflow 

10.1. Next-Generation Sequencing Technologies Market, by Workflow

10.1.1. Pre-Sequencing

10.1.1.1. Market Revenue and Forecast

10.1.2. Sequencing

10.1.2.1. Market Revenue and Forecast

10.1.3. NGS Data Analysis

10.1.3.1. Market Revenue and Forecast

Chapter 11. Global Next-Generation Sequencing Technologies Market, By End Use 

11.1. Next-Generation Sequencing Technologies Market, by End Use

11.1.1. Academic Research

11.1.1.1. Market Revenue and Forecast

11.1.2. Clinical Research

11.1.2.1. Market Revenue and Forecast

11.1.3. Hospitals & Clinics

11.1.3.1. Market Revenue and Forecast

11.1.4. Pharma & Biotech Companies

11.1.4.1. Market Revenue and Forecast

11.1.5. Other Users

11.1.5.1. Market Revenue and Forecast

Chapter 12. Global Next-Generation Sequencing Technologies Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Technology

12.1.2. Market Revenue and Forecast, by Application

12.1.3. Market Revenue and Forecast, by Workflow

12.1.4. Market Revenue and Forecast, by End Use

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Technology

12.1.5.2. Market Revenue and Forecast, by Application

12.1.5.3. Market Revenue and Forecast, by Workflow

12.1.5.4. Market Revenue and Forecast, by End Use

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Technology

12.1.6.2. Market Revenue and Forecast, by Application

12.1.6.3. Market Revenue and Forecast, by Workflow

12.1.6.4. Market Revenue and Forecast, by End Use

12.2. Europe

12.2.1. Market Revenue and Forecast, by Technology

12.2.2. Market Revenue and Forecast, by Application

12.2.3. Market Revenue and Forecast, by Workflow

12.2.4. Market Revenue and Forecast, by End Use

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Technology

12.2.5.2. Market Revenue and Forecast, by Application

12.2.5.3. Market Revenue and Forecast, by Workflow

12.2.5.4. Market Revenue and Forecast, by End Use

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Technology

12.2.6.2. Market Revenue and Forecast, by Application

12.2.6.3. Market Revenue and Forecast, by Workflow

12.2.6.4. Market Revenue and Forecast, by End Use

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Technology

12.2.7.2. Market Revenue and Forecast, by Application

12.2.7.3. Market Revenue and Forecast, by Workflow

12.2.7.4. Market Revenue and Forecast, by End Use

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Technology

12.2.8.2. Market Revenue and Forecast, by Application

12.2.8.3. Market Revenue and Forecast, by Workflow

12.2.8.4. Market Revenue and Forecast, by End Use

12.3. APAC

12.3.1. Market Revenue and Forecast, by Technology

12.3.2. Market Revenue and Forecast, by Application

12.3.3. Market Revenue and Forecast, by Workflow

12.3.4. Market Revenue and Forecast, by End Use

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Technology

12.3.5.2. Market Revenue and Forecast, by Application

12.3.5.3. Market Revenue and Forecast, by Workflow

12.3.5.4. Market Revenue and Forecast, by End Use

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Technology

12.3.6.2. Market Revenue and Forecast, by Application

12.3.6.3. Market Revenue and Forecast, by Workflow

12.3.6.4. Market Revenue and Forecast, by End Use

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Technology

12.3.7.2. Market Revenue and Forecast, by Application

12.3.7.3. Market Revenue and Forecast, by Workflow

12.3.7.4. Market Revenue and Forecast, by End Use

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Technology

12.3.8.2. Market Revenue and Forecast, by Application

12.3.8.3. Market Revenue and Forecast, by Workflow

12.3.8.4. Market Revenue and Forecast, by End Use

12.4. MEA

12.4.1. Market Revenue and Forecast, by Technology

12.4.2. Market Revenue and Forecast, by Application

12.4.3. Market Revenue and Forecast, by Workflow

12.4.4. Market Revenue and Forecast, by End Use

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Technology

12.4.5.2. Market Revenue and Forecast, by Application

12.4.5.3. Market Revenue and Forecast, by Workflow

12.4.5.4. Market Revenue and Forecast, by End Use

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Technology

12.4.6.2. Market Revenue and Forecast, by Application

12.4.6.3. Market Revenue and Forecast, by Workflow

12.4.6.4. Market Revenue and Forecast, by End Use

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Technology

12.4.7.2. Market Revenue and Forecast, by Application

12.4.7.3. Market Revenue and Forecast, by Workflow

12.4.7.4. Market Revenue and Forecast, by End Use

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Technology

12.4.8.2. Market Revenue and Forecast, by Application

12.4.8.3. Market Revenue and Forecast, by Workflow

12.4.8.4. Market Revenue and Forecast, by End Use

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Technology

12.5.2. Market Revenue and Forecast, by Application

12.5.3. Market Revenue and Forecast, by Workflow

12.5.4. Market Revenue and Forecast, by End Use

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Technology

12.5.5.2. Market Revenue and Forecast, by Application

12.5.5.3. Market Revenue and Forecast, by Workflow

12.5.5.4. Market Revenue and Forecast, by End Use

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Technology

12.5.6.2. Market Revenue and Forecast, by Application

12.5.6.3. Market Revenue and Forecast, by Workflow

12.5.6.4. Market Revenue and Forecast, by End Use

Chapter 13. Company Profiles

13.1. Genomatix

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. PierianDx

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. DNASTAR, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Perkin Elmer, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Oxford Nanopore Technologies

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Bio-Rad Laboratories, Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. QIAGEN

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. F. Hoffman-La Roche Ltd.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Thermo Fisher Scientific, Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Perkin Elmer, Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms